eFFECTOR Therapeutics
0 followers
‌
eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs).
Industries
Headquarters
Employees
Links
Org chart
Steve Worland
President & CEO
Steve Worland
Collapse
Doug Warner
Chief Medical Officer
Gary Chiang
VP, Translational Science
Katie Ard
Director of Development Operations
Thomas Kevin Gregorczyk
Senior Director, Development Operations
